Kazerooni E A
Department of Radiology, University of Michigan Medical Center, Ann Arbor, USA.
Clin Chest Med. 1999 Dec;20(4):845-61. doi: 10.1016/s0272-5231(05)70258-6.
Lung volume reduction surgery has created an opportunity for the advanced imaging of emphysema. Patients with CT or perfusion scintigraphy demonstrating an upper- or lower-lobe-predominant pattern of emphysema have better patient outcomes after LVRS than patients with emphysema diffusely or homogeneously distributed throughout the lungs. Some patients with diffuse or homogeneous emphysema may demonstrate improvement in function or dyspnea after surgery, but the magnitude of the improvement seen is less than in patients with heterogeneous emphysema, and the duration of benefit is not known. An ongoing, multicenter National Heart, Lung, and Blood Institute (NHLBI)/Health Care Financing Association (HCFA) sponsored trial of LVRS aims to determine whether LVRS together with maximal medical therapy and pulmonary rehabilitation improves patient outcomes compared with maximal medical therapy and pulmonary rehabilitation alone. This study will address the duration of clinical benefit and the cost-effectiveness of LVRS.
肺减容手术为肺气肿的高级影像学检查创造了机会。通过CT或灌注闪烁扫描显示为上叶或下叶为主型肺气肿的患者,与肺部弥漫性或均匀分布肺气肿的患者相比,接受肺减容手术后的患者预后更好。一些弥漫性或均匀性肺气肿患者术后功能或呼吸困难可能有所改善,但改善程度小于异质性肺气肿患者,且获益持续时间尚不清楚。美国国立心肺血液研究所(NHLBI)/医疗保健融资协会(HCFA)正在进行的一项多中心资助的肺减容手术试验旨在确定与单纯最大程度的药物治疗和肺康复相比,肺减容手术联合最大程度的药物治疗和肺康复是否能改善患者预后。这项研究将探讨肺减容手术临床获益的持续时间和成本效益。